Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000242872 | SCV000305410 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Invitae | RCV001516678 | SCV001724990 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001838525 | SCV002098909 | benign | Diaphyseal dysplasia | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001838526 | SCV002098911 | benign | Inflammatory bowel disease, immunodeficiency, and encephalopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002496341 | SCV002807082 | benign | Meckel syndrome, type 10 | 2021-08-11 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000242872 | SCV004233042 | benign | not specified | 2024-01-24 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 78% of patients studied by a panel of primary immunodeficiencies. Number of patients: 74. Only high quality variants are reported. |
OMIM | RCV000013360 | SCV000033607 | risk factor | Cystic fibrosis | 2008-07-15 | no assertion criteria provided | literature only | |
OMIM | RCV000013361 | SCV000033608 | risk factor | Breast cancer, invasive, susceptibility to | 2008-07-15 | no assertion criteria provided | literature only | |
Diagnostic Laboratory, |
RCV000242872 | SCV001740315 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000242872 | SCV001952482 | benign | not specified | no assertion criteria provided | clinical testing |